The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,748.00
Bid: 3,746.00
Ask: 3,750.00
Change: 38.00 (1.02%)
Spread: 4.00 (0.107%)
Open: 3,730.00
High: 3,764.00
Low: 3,706.00
Prev. Close: 3,710.00
DPLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

20 Jan 2021 07:00

RNS Number : 2115M
Diploma PLC
20 January 2021
 

 

DIPLOMA PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

 

FOR IMMEDIATE RELEASE

 

20 January 2021

 

 

DIPLOMA PLC

 

 

FIRST QUARTER TRADING UPDATE

 

STRONG TRADING AND THREE HIGH QUALITY BOLT-ON ACQUISITIONS IN Q1

 

Diploma PLC, the international group supplying specialised products and services, is today issuing its first quarter trading update in respect of the year ending 30 September 2021, ahead of the Company's closed door AGM today at 12.00, midday.

 

 

Group

 

Diploma has made a strong start to the year with improved trends in underlying trading across all of the Group's three Sectors in the first quarter. The Group delivered underlying revenues in line with last year's pre-Covid comparative, reflecting strong execution of our organic growth initiatives. Reported Group revenues in the first quarter ended 31 December 2020 increased by 24% over the comparable period, driven by an excellent first quarter contribution from Windy City Wire (WCW) which is trading very well following a smooth transition into the Group.

 

The following table sets out the year-on-year revenue performance by Sector for Q1 alongside a reminder of the exit rates reported for September 2020:

 

Sector performance

Q1

Sept 20

Life Sciences

Underlying

+8%

+2%

 

Reported

+10%

 

 

 

 

 

Seals

Underlying

-2%

-4%

 

Reported

-0%

 

 

 

 

 

Controls

Underlying

-1%

-18%

 

Reported

+71%

 

 

 

 

 

Group

Underlying

+0%

-7%

 

Reported

+24%

 

 

 

Life Sciences

 

Life Sciences delivered strong underlying growth of 8%, driven by an encouraging performance in consumables in both clinical diagnostics and specialty surgical equipment in Australia and Canada, as well as higher than normal levels of capital installations due to pent up demand from last year's lockdowns. In Q2, we expect growth rates to moderate with lockdowns in Canada impacting capital sales and surgical procedures. However, the Sector remains well positioned to capitalise on the backlog of surgical procedures and lab testing as the year progresses.

 

 

Seals

 

Seals traded well with underlying revenues improving to -2%. The Group continues to see strong performances from International Seals due to the diversity of end markets and North American Aftermarket due to continued strong repair shop demand. The North American OEM business has been recovering well in the last two quarters, and we are confident in its prospects under a strengthened management team. The transition to the new Aftermarket automated facility in Louisville has completed successfully and will support future market share gains.

 

 

Controls

 

Underlying revenues have seen a strong recovery since the start of year, improving to -1% reflecting the execution of initiatives to diversify the Sector's revenue streams. Reported revenues were up 71% due to the contribution from WCW. After a smooth transition into the Group WCW is trading very well, growing both revenues and profits broadly in line with their impressive track record and ahead of our initial expectations. Some benefits from Brexit inventory build in Q1 are likely to unwind in the coming weeks and, along with the impact of further UK lockdowns, may impact Q2 trading in Controls. However, the Sector's healthier revenue profile will underpin a return to growth this year.

 

 

Acquisitions

 

Bolt-on acquisitions remain a core part of the Group's strategy. The first quarter has been active with £48.8m invested in three high quality, strategically important bolt-on acquisitions to build scale in core markets and enhance our organic growth ambitions:

 

· Simonsen & Weel (annualised revenues ca.£25m), an excellent Healthcare business based in Denmark and building the Life Sciences Sector's presence in Northern Europe;

· FITT Resources (annualised revenues ca.£13m), a well established, high quality Seals business that significantly strengthens the Sector's footprint in Eastern Australia; and

· Power Dynamics (annualised revenues ca.£5m), a gasket bolt-on for VSP within our NA Seals business, expanding VSP's presence across the Northern US.

 

 

Financial position

 

As previously stated, the Group's equity raise in September 2020 allowed Diploma to retain balance sheet flexibility following the acquisition of WCW. This has enabled the Group to pursue its bolt-on acquisition strategy while maintaining a strong financial position. After three bolt-on acquisitions in Q1, net debt at year-end is expected to be at around 1.2x EBITDA.

 

 

Outlook

 

Inevitably uncertainties remain with respect to the duration and impact of the Covid-19 pandemic. However, while the pandemic may modestly affect Q2 revenues, we are pleased with the Group's trading performance. Excluding the contribution from the acquisitions completed in the quarter, full year expectations for the underlying business remain positive and unchanged. 

 

 

Enquiries:

 

Diploma PLC -

Johnny Thomson, Chief Executive Officer

+44 (0)20 7549 5700

Barbara Gibbes, Chief Financial Officer

 

 

 

 

 

Tulchan Communications -

+44 (0)20 7353 4200

Martin Robinson

 

Olivia Peters

 

 

 

 

 

 

Notes:

 

1. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of Diploma PLC. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2. Diploma PLC uses alternative performance measures as key financial indicators to assess the underlying performance of the Group. All references in this Statement to "underlying" revenues refer to reported results on a constant currency basis and before any contribution from acquired or disposed businesses.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

 

 

 

 

 

LEI: 2138008OGI7VYG8FGR19

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUGUGUPGGAB
Date   Source Headline
16th Jan 20194:19 pmRNSResult of AGM
16th Jan 20197:01 amRNSDirectorate Change
16th Jan 20197:00 amRNSTrading Statement
7th Dec 20184:09 pmRNSDirector/PDMR Shareholding
7th Dec 20183:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20184:26 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSFinal Results
12th Oct 20187:00 amRNSAcquisition
3rd Sep 20184:45 pmRNSBoard Committee Change
29th Aug 20187:01 amRNSDirectorate Change
29th Aug 20187:00 amRNSTrading Statement
22nd Aug 20187:00 amRNSAcquisition
10th Jul 20181:46 pmRNSHolding(s) in Company
12th Jun 20182:59 pmRNSHolding(s) in Company
16th May 20182:41 pmRNSDirector Declaration
15th May 20184:20 pmRNSDirector/PDMR Shareholding
15th May 20184:09 pmRNSDirector/PDMR Shareholding
14th May 20187:00 amRNSHalf-year Report
9th May 20187:00 amRNSDirectorate Change
23rd Apr 20187:00 amRNSDirectorate Change
28th Mar 20187:00 amRNSTrading Update
21st Mar 20189:30 amRNSHolding(s) in Company
20th Mar 20184:00 pmRNSHolding(s) in Company
6th Feb 20189:49 amRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSDirectorate Change
23rd Jan 20184:00 pmRNSDirector Declaration
17th Jan 20184:30 pmRNSResult of AGM
17th Jan 20187:00 amRNSTrading Statement
28th Dec 20174:13 pmRNSDirector/PDMR Shareholding
12th Dec 20173:18 pmRNSHolding(s) in Company
8th Dec 20173:00 pmRNSAnnual Financial Report & Notice of AGM
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding
20th Nov 20177:00 amRNSFinal Results
25th Oct 201710:00 amRNSHolding(s) in Company
25th Oct 20179:50 amRNSHolding(s) in Company
29th Sep 20174:00 pmRNSDirector Declaration
27th Sep 20177:00 amRNSDirectorate Change
26th Sep 201712:41 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSResult of Statutory Audit Tender
30th Aug 20177:00 amRNSTrading Update
17th Aug 20173:29 pmRNSHolding(s) in Company
16th Jun 20179:00 amRNSHolding(s) in Company
14th Jun 20174:05 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSHalf-year Report
20th Apr 20177:00 amRNSAcquisition
18th Apr 20179:44 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSTrading Update
23rd Mar 20173:05 pmRNSDirector/PDMR Shareholding
13th Mar 20172:08 pmRNSHolding(s) in Company
16th Feb 20175:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.